nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP1A2—Carmustine—lymphatic system cancer	0.14	0.231	CbGbCtD
Sertraline—CYP2C19—Teniposide—lymphatic system cancer	0.102	0.168	CbGbCtD
Sertraline—CYP2C9—Teniposide—lymphatic system cancer	0.085	0.14	CbGbCtD
Sertraline—ABCB1—Mitoxantrone—lymphatic system cancer	0.0577	0.095	CbGbCtD
Sertraline—CYP3A4—Cytarabine—lymphatic system cancer	0.0502	0.0827	CbGbCtD
Sertraline—CYP3A4—Teniposide—lymphatic system cancer	0.0494	0.0814	CbGbCtD
Sertraline—ABCB1—Vincristine—lymphatic system cancer	0.0397	0.0654	CbGbCtD
Sertraline—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0346	0.0569	CbGbCtD
Sertraline—ABCB1—Methotrexate—lymphatic system cancer	0.0241	0.0396	CbGbCtD
Sertraline—CYP3A4—Vincristine—lymphatic system cancer	0.0238	0.0392	CbGbCtD
Sertraline—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000507	0.00129	CcSEcCtD
Sertraline—Alopecia—Mitoxantrone—lymphatic system cancer	0.000504	0.00128	CcSEcCtD
Sertraline—Confusional state—Bleomycin—lymphatic system cancer	0.000504	0.00128	CcSEcCtD
Sertraline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000502	0.00128	CcSEcCtD
Sertraline—Tremor—Carmustine—lymphatic system cancer	0.000501	0.00127	CcSEcCtD
Sertraline—Oedema—Bleomycin—lymphatic system cancer	0.0005	0.00127	CcSEcCtD
Sertraline—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0005	0.00127	CcSEcCtD
Sertraline—Erythema—Mitoxantrone—lymphatic system cancer	0.000497	0.00126	CcSEcCtD
Sertraline—Anaemia—Carmustine—lymphatic system cancer	0.000494	0.00126	CcSEcCtD
Sertraline—Back pain—Vincristine—lymphatic system cancer	0.000493	0.00126	CcSEcCtD
Sertraline—Vomiting—Teniposide—lymphatic system cancer	0.000493	0.00126	CcSEcCtD
Sertraline—Agitation—Carmustine—lymphatic system cancer	0.000491	0.00125	CcSEcCtD
Sertraline—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000489	0.00125	CcSEcCtD
Sertraline—Asthenia—Fludarabine—lymphatic system cancer	0.000489	0.00124	CcSEcCtD
Sertraline—Rash—Teniposide—lymphatic system cancer	0.000489	0.00124	CcSEcCtD
Sertraline—Dermatitis—Teniposide—lymphatic system cancer	0.000488	0.00124	CcSEcCtD
Sertraline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Sertraline—Headache—Teniposide—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Sertraline—Pruritus—Fludarabine—lymphatic system cancer	0.000482	0.00123	CcSEcCtD
Sertraline—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000482	0.00123	CcSEcCtD
Sertraline—Back pain—Mitoxantrone—lymphatic system cancer	0.000481	0.00122	CcSEcCtD
Sertraline—Leukopenia—Carmustine—lymphatic system cancer	0.000478	0.00122	CcSEcCtD
Sertraline—Anorexia—Bleomycin—lymphatic system cancer	0.000476	0.00121	CcSEcCtD
Sertraline—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000472	0.0012	CcSEcCtD
Sertraline—Anaemia—Vincristine—lymphatic system cancer	0.000471	0.0012	CcSEcCtD
Sertraline—Agitation—Vincristine—lymphatic system cancer	0.000469	0.00119	CcSEcCtD
Sertraline—Photosensitivity—Methotrexate—lymphatic system cancer	0.000468	0.00119	CcSEcCtD
Sertraline—Polyuria—Methotrexate—lymphatic system cancer	0.000468	0.00119	CcSEcCtD
Sertraline—Hypotension—Bleomycin—lymphatic system cancer	0.000467	0.00119	CcSEcCtD
Sertraline—Diarrhoea—Fludarabine—lymphatic system cancer	0.000466	0.00119	CcSEcCtD
Sertraline—Convulsion—Carmustine—lymphatic system cancer	0.000463	0.00118	CcSEcCtD
Sertraline—Hypertension—Carmustine—lymphatic system cancer	0.000461	0.00117	CcSEcCtD
Sertraline—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000461	0.00117	CcSEcCtD
Sertraline—Nausea—Teniposide—lymphatic system cancer	0.000461	0.00117	CcSEcCtD
Sertraline—Anaemia—Mitoxantrone—lymphatic system cancer	0.000459	0.00117	CcSEcCtD
Sertraline—Vertigo—Vincristine—lymphatic system cancer	0.000458	0.00117	CcSEcCtD
Sertraline—Hepatic failure—Methotrexate—lymphatic system cancer	0.000457	0.00116	CcSEcCtD
Sertraline—Leukopenia—Vincristine—lymphatic system cancer	0.000457	0.00116	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000455	0.00116	CcSEcCtD
Sertraline—Chest pain—Carmustine—lymphatic system cancer	0.000455	0.00116	CcSEcCtD
Sertraline—Myalgia—Carmustine—lymphatic system cancer	0.000455	0.00116	CcSEcCtD
Sertraline—Anxiety—Carmustine—lymphatic system cancer	0.000453	0.00115	CcSEcCtD
Sertraline—Paraesthesia—Bleomycin—lymphatic system cancer	0.000449	0.00114	CcSEcCtD
Sertraline—Malaise—Mitoxantrone—lymphatic system cancer	0.000448	0.00114	CcSEcCtD
Sertraline—Dyspnoea—Bleomycin—lymphatic system cancer	0.000445	0.00113	CcSEcCtD
Sertraline—Renal failure acute—Methotrexate—lymphatic system cancer	0.000445	0.00113	CcSEcCtD
Sertraline—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000445	0.00113	CcSEcCtD
Sertraline—Convulsion—Vincristine—lymphatic system cancer	0.000442	0.00113	CcSEcCtD
Sertraline—Hypertension—Vincristine—lymphatic system cancer	0.00044	0.00112	CcSEcCtD
Sertraline—Confusional state—Carmustine—lymphatic system cancer	0.00044	0.00112	CcSEcCtD
Sertraline—Oedema—Carmustine—lymphatic system cancer	0.000436	0.00111	CcSEcCtD
Sertraline—Decreased appetite—Bleomycin—lymphatic system cancer	0.000434	0.00111	CcSEcCtD
Sertraline—Myalgia—Vincristine—lymphatic system cancer	0.000434	0.00111	CcSEcCtD
Sertraline—Cough—Mitoxantrone—lymphatic system cancer	0.000433	0.0011	CcSEcCtD
Sertraline—Vomiting—Fludarabine—lymphatic system cancer	0.000433	0.0011	CcSEcCtD
Sertraline—Convulsion—Mitoxantrone—lymphatic system cancer	0.00043	0.0011	CcSEcCtD
Sertraline—Rash—Fludarabine—lymphatic system cancer	0.00043	0.00109	CcSEcCtD
Sertraline—Dermatitis—Fludarabine—lymphatic system cancer	0.000429	0.00109	CcSEcCtD
Sertraline—Hypertension—Mitoxantrone—lymphatic system cancer	0.000429	0.00109	CcSEcCtD
Sertraline—Pain—Bleomycin—lymphatic system cancer	0.000427	0.00109	CcSEcCtD
Sertraline—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000427	0.00109	CcSEcCtD
Sertraline—Headache—Fludarabine—lymphatic system cancer	0.000427	0.00109	CcSEcCtD
Sertraline—Tachycardia—Carmustine—lymphatic system cancer	0.000426	0.00108	CcSEcCtD
Sertraline—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000425	0.00108	CcSEcCtD
Sertraline—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000423	0.00108	CcSEcCtD
Sertraline—Chest pain—Mitoxantrone—lymphatic system cancer	0.000423	0.00108	CcSEcCtD
Sertraline—Myalgia—Mitoxantrone—lymphatic system cancer	0.000423	0.00108	CcSEcCtD
Sertraline—Anxiety—Mitoxantrone—lymphatic system cancer	0.000421	0.00107	CcSEcCtD
Sertraline—Discomfort—Mitoxantrone—lymphatic system cancer	0.000418	0.00106	CcSEcCtD
Sertraline—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000416	0.00106	CcSEcCtD
Sertraline—Oedema—Vincristine—lymphatic system cancer	0.000416	0.00106	CcSEcCtD
Sertraline—Anorexia—Carmustine—lymphatic system cancer	0.000416	0.00106	CcSEcCtD
Sertraline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000412	0.00105	CcSEcCtD
Sertraline—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000411	0.00105	CcSEcCtD
Sertraline—Confusional state—Mitoxantrone—lymphatic system cancer	0.000409	0.00104	CcSEcCtD
Sertraline—Nervous system disorder—Vincristine—lymphatic system cancer	0.000408	0.00104	CcSEcCtD
Sertraline—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000408	0.00104	CcSEcCtD
Sertraline—Hypotension—Carmustine—lymphatic system cancer	0.000407	0.00104	CcSEcCtD
Sertraline—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000405	0.00103	CcSEcCtD
Sertraline—Oedema—Mitoxantrone—lymphatic system cancer	0.000405	0.00103	CcSEcCtD
Sertraline—Nausea—Fludarabine—lymphatic system cancer	0.000405	0.00103	CcSEcCtD
Sertraline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000402	0.00102	CcSEcCtD
Sertraline—Shock—Mitoxantrone—lymphatic system cancer	0.000399	0.00102	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000397	0.00101	CcSEcCtD
Sertraline—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000397	0.00101	CcSEcCtD
Sertraline—Urticaria—Bleomycin—lymphatic system cancer	0.000397	0.00101	CcSEcCtD
Sertraline—Anorexia—Vincristine—lymphatic system cancer	0.000397	0.00101	CcSEcCtD
Sertraline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000396	0.00101	CcSEcCtD
Sertraline—Body temperature increased—Bleomycin—lymphatic system cancer	0.000395	0.00101	CcSEcCtD
Sertraline—Insomnia—Carmustine—lymphatic system cancer	0.000394	0.001	CcSEcCtD
Sertraline—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000394	0.001	CcSEcCtD
Sertraline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000392	0.000998	CcSEcCtD
Sertraline—Paraesthesia—Carmustine—lymphatic system cancer	0.000392	0.000997	CcSEcCtD
Sertraline—Mood swings—Methotrexate—lymphatic system cancer	0.000389	0.000991	CcSEcCtD
Sertraline—Hypotension—Vincristine—lymphatic system cancer	0.000389	0.000991	CcSEcCtD
Sertraline—Dyspnoea—Carmustine—lymphatic system cancer	0.000389	0.00099	CcSEcCtD
Sertraline—Somnolence—Carmustine—lymphatic system cancer	0.000388	0.000987	CcSEcCtD
Sertraline—Anorexia—Mitoxantrone—lymphatic system cancer	0.000386	0.000984	CcSEcCtD
Sertraline—Ataxia—Methotrexate—lymphatic system cancer	0.000386	0.000984	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000379	0.000966	CcSEcCtD
Sertraline—Decreased appetite—Carmustine—lymphatic system cancer	0.000379	0.000965	CcSEcCtD
Sertraline—Hypotension—Mitoxantrone—lymphatic system cancer	0.000379	0.000965	CcSEcCtD
Sertraline—Insomnia—Vincristine—lymphatic system cancer	0.000377	0.000959	CcSEcCtD
Sertraline—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000376	0.000959	CcSEcCtD
Sertraline—Paraesthesia—Vincristine—lymphatic system cancer	0.000374	0.000952	CcSEcCtD
Sertraline—Pain—Carmustine—lymphatic system cancer	0.000373	0.00095	CcSEcCtD
Sertraline—Constipation—Carmustine—lymphatic system cancer	0.000373	0.00095	CcSEcCtD
Sertraline—Breast disorder—Methotrexate—lymphatic system cancer	0.000371	0.000946	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00037	0.000942	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000369	0.000941	CcSEcCtD
Sertraline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000368	0.000937	CcSEcCtD
Sertraline—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000364	0.000927	CcSEcCtD
Sertraline—Decreased appetite—Vincristine—lymphatic system cancer	0.000362	0.000921	CcSEcCtD
Sertraline—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000361	0.00092	CcSEcCtD
Sertraline—Somnolence—Mitoxantrone—lymphatic system cancer	0.00036	0.000918	CcSEcCtD
Sertraline—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000359	0.000915	CcSEcCtD
Sertraline—Feeling abnormal—Carmustine—lymphatic system cancer	0.000359	0.000915	CcSEcCtD
Sertraline—Fatigue—Vincristine—lymphatic system cancer	0.000359	0.000914	CcSEcCtD
Sertraline—Asthenia—Bleomycin—lymphatic system cancer	0.000358	0.000913	CcSEcCtD
Sertraline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000357	0.000909	CcSEcCtD
Sertraline—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000357	0.000908	CcSEcCtD
Sertraline—Pain—Vincristine—lymphatic system cancer	0.000356	0.000906	CcSEcCtD
Sertraline—Constipation—Vincristine—lymphatic system cancer	0.000356	0.000906	CcSEcCtD
Sertraline—Pruritus—Bleomycin—lymphatic system cancer	0.000353	0.0009	CcSEcCtD
Sertraline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000352	0.000897	CcSEcCtD
Sertraline—Fatigue—Mitoxantrone—lymphatic system cancer	0.00035	0.00089	CcSEcCtD
Sertraline—Pancreatitis—Methotrexate—lymphatic system cancer	0.000348	0.000887	CcSEcCtD
Sertraline—Pain—Mitoxantrone—lymphatic system cancer	0.000347	0.000883	CcSEcCtD
Sertraline—Constipation—Mitoxantrone—lymphatic system cancer	0.000347	0.000883	CcSEcCtD
Sertraline—Abdominal pain—Carmustine—lymphatic system cancer	0.000345	0.000878	CcSEcCtD
Sertraline—Body temperature increased—Carmustine—lymphatic system cancer	0.000345	0.000878	CcSEcCtD
Sertraline—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00034	0.000867	CcSEcCtD
Sertraline—Pancytopenia—Methotrexate—lymphatic system cancer	0.000337	0.000859	CcSEcCtD
Sertraline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000334	0.000851	CcSEcCtD
Sertraline—Dysuria—Methotrexate—lymphatic system cancer	0.000332	0.000846	CcSEcCtD
Sertraline—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000332	0.000844	CcSEcCtD
Sertraline—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00033	0.000841	CcSEcCtD
Sertraline—Abdominal pain—Vincristine—lymphatic system cancer	0.000329	0.000838	CcSEcCtD
Sertraline—Body temperature increased—Vincristine—lymphatic system cancer	0.000329	0.000838	CcSEcCtD
Sertraline—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000327	0.000833	CcSEcCtD
Sertraline—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000324	0.000826	CcSEcCtD
Sertraline—Urticaria—Mitoxantrone—lymphatic system cancer	0.000322	0.00082	CcSEcCtD
Sertraline—Hypersensitivity—Carmustine—lymphatic system cancer	0.000321	0.000818	CcSEcCtD
Sertraline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00032	0.000816	CcSEcCtD
Sertraline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00032	0.000816	CcSEcCtD
Sertraline—Vomiting—Bleomycin—lymphatic system cancer	0.000318	0.000809	CcSEcCtD
Sertraline—Drowsiness—Methotrexate—lymphatic system cancer	0.000317	0.000806	CcSEcCtD
Sertraline—Depression—Methotrexate—lymphatic system cancer	0.000316	0.000804	CcSEcCtD
Sertraline—Rash—Bleomycin—lymphatic system cancer	0.000315	0.000802	CcSEcCtD
Sertraline—Dermatitis—Bleomycin—lymphatic system cancer	0.000315	0.000801	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000314	0.0008	CcSEcCtD
Sertraline—Asthenia—Carmustine—lymphatic system cancer	0.000313	0.000797	CcSEcCtD
Sertraline—Stomatitis—Methotrexate—lymphatic system cancer	0.000309	0.000786	CcSEcCtD
Sertraline—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000308	0.000784	CcSEcCtD
Sertraline—Hypersensitivity—Vincristine—lymphatic system cancer	0.000307	0.000781	CcSEcCtD
Sertraline—Sweating—Methotrexate—lymphatic system cancer	0.000304	0.000773	CcSEcCtD
Sertraline—Haematuria—Methotrexate—lymphatic system cancer	0.000302	0.000769	CcSEcCtD
Sertraline—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.0003	0.000763	CcSEcCtD
Sertraline—Epistaxis—Methotrexate—lymphatic system cancer	0.000299	0.000761	CcSEcCtD
Sertraline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000299	0.000761	CcSEcCtD
Sertraline—Asthenia—Vincristine—lymphatic system cancer	0.000299	0.000761	CcSEcCtD
Sertraline—Diarrhoea—Carmustine—lymphatic system cancer	0.000298	0.00076	CcSEcCtD
Sertraline—Nausea—Bleomycin—lymphatic system cancer	0.000297	0.000756	CcSEcCtD
Sertraline—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000296	0.000753	CcSEcCtD
Sertraline—Asthenia—Mitoxantrone—lymphatic system cancer	0.000291	0.000741	CcSEcCtD
Sertraline—Dizziness—Carmustine—lymphatic system cancer	0.000288	0.000734	CcSEcCtD
Sertraline—Haemoglobin—Methotrexate—lymphatic system cancer	0.000286	0.000728	CcSEcCtD
Sertraline—Diarrhoea—Vincristine—lymphatic system cancer	0.000285	0.000725	CcSEcCtD
Sertraline—Haemorrhage—Methotrexate—lymphatic system cancer	0.000284	0.000724	CcSEcCtD
Sertraline—Hepatitis—Methotrexate—lymphatic system cancer	0.000284	0.000724	CcSEcCtD
Sertraline—Pharyngitis—Methotrexate—lymphatic system cancer	0.000282	0.000719	CcSEcCtD
Sertraline—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000281	0.000715	CcSEcCtD
Sertraline—Urethral disorder—Methotrexate—lymphatic system cancer	0.000279	0.00071	CcSEcCtD
Sertraline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000277	0.000706	CcSEcCtD
Sertraline—Vomiting—Carmustine—lymphatic system cancer	0.000277	0.000706	CcSEcCtD
Sertraline—Dizziness—Vincristine—lymphatic system cancer	0.000275	0.000701	CcSEcCtD
Sertraline—Rash—Carmustine—lymphatic system cancer	0.000275	0.0007	CcSEcCtD
Sertraline—Dermatitis—Carmustine—lymphatic system cancer	0.000275	0.0007	CcSEcCtD
Sertraline—Visual impairment—Methotrexate—lymphatic system cancer	0.000274	0.000698	CcSEcCtD
Sertraline—Headache—Carmustine—lymphatic system cancer	0.000273	0.000696	CcSEcCtD
Sertraline—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000269	0.000685	CcSEcCtD
Sertraline—Eye disorder—Methotrexate—lymphatic system cancer	0.000266	0.000677	CcSEcCtD
Sertraline—Tinnitus—Methotrexate—lymphatic system cancer	0.000265	0.000675	CcSEcCtD
Sertraline—Vomiting—Vincristine—lymphatic system cancer	0.000265	0.000674	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000264	0.000672	CcSEcCtD
Sertraline—Rash—Vincristine—lymphatic system cancer	0.000262	0.000668	CcSEcCtD
Sertraline—Dermatitis—Vincristine—lymphatic system cancer	0.000262	0.000668	CcSEcCtD
Sertraline—Headache—Vincristine—lymphatic system cancer	0.000261	0.000664	CcSEcCtD
Sertraline—Nausea—Carmustine—lymphatic system cancer	0.000259	0.00066	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—lymphatic system cancer	0.000258	0.000657	CcSEcCtD
Sertraline—Vomiting—Mitoxantrone—lymphatic system cancer	0.000258	0.000656	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—lymphatic system cancer	0.000257	0.000654	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000256	0.000652	CcSEcCtD
Sertraline—Rash—Mitoxantrone—lymphatic system cancer	0.000256	0.000651	CcSEcCtD
Sertraline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000255	0.00065	CcSEcCtD
Sertraline—Chills—Methotrexate—lymphatic system cancer	0.000255	0.00065	CcSEcCtD
Sertraline—Headache—Mitoxantrone—lymphatic system cancer	0.000254	0.000647	CcSEcCtD
Sertraline—Alopecia—Methotrexate—lymphatic system cancer	0.000251	0.00064	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—lymphatic system cancer	0.000249	0.000634	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—lymphatic system cancer	0.000247	0.00063	CcSEcCtD
Sertraline—Erythema—Methotrexate—lymphatic system cancer	0.000247	0.00063	CcSEcCtD
Sertraline—Nausea—Vincristine—lymphatic system cancer	0.000247	0.00063	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—lymphatic system cancer	0.000242	0.000617	CcSEcCtD
Sertraline—Nausea—Mitoxantrone—lymphatic system cancer	0.000241	0.000613	CcSEcCtD
Sertraline—Back pain—Methotrexate—lymphatic system cancer	0.000239	0.00061	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00023	0.000585	CcSEcCtD
Sertraline—Anaemia—Methotrexate—lymphatic system cancer	0.000229	0.000583	CcSEcCtD
Sertraline—Malaise—Methotrexate—lymphatic system cancer	0.000223	0.000568	CcSEcCtD
Sertraline—Vertigo—Methotrexate—lymphatic system cancer	0.000222	0.000566	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—lymphatic system cancer	0.000222	0.000564	CcSEcCtD
Sertraline—Cough—Methotrexate—lymphatic system cancer	0.000216	0.00055	CcSEcCtD
Sertraline—Convulsion—Methotrexate—lymphatic system cancer	0.000214	0.000546	CcSEcCtD
Sertraline—Myalgia—Methotrexate—lymphatic system cancer	0.000211	0.000537	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—lymphatic system cancer	0.000211	0.000537	CcSEcCtD
Sertraline—Chest pain—Methotrexate—lymphatic system cancer	0.000211	0.000537	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000209	0.000533	CcSEcCtD
Sertraline—Discomfort—Methotrexate—lymphatic system cancer	0.000208	0.00053	CcSEcCtD
Sertraline—Confusional state—Methotrexate—lymphatic system cancer	0.000204	0.000519	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000202	0.000514	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000198	0.000504	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000198	0.000504	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—lymphatic system cancer	0.000196	0.0005	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000195	0.000497	CcSEcCtD
Sertraline—Anorexia—Methotrexate—lymphatic system cancer	0.000193	0.00049	CcSEcCtD
Sertraline—Hypotension—Methotrexate—lymphatic system cancer	0.000189	0.000481	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000184	0.000469	CcSEcCtD
Sertraline—Insomnia—Methotrexate—lymphatic system cancer	0.000183	0.000465	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—lymphatic system cancer	0.000181	0.000462	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—lymphatic system cancer	0.00018	0.000459	CcSEcCtD
Sertraline—Somnolence—Methotrexate—lymphatic system cancer	0.00018	0.000457	CcSEcCtD
Sertraline—Dyspepsia—Methotrexate—lymphatic system cancer	0.000178	0.000453	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000176	0.000447	CcSEcCtD
Sertraline—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000174	0.000444	CcSEcCtD
Sertraline—Fatigue—Methotrexate—lymphatic system cancer	0.000174	0.000443	CcSEcCtD
Sertraline—Pain—Methotrexate—lymphatic system cancer	0.000173	0.00044	CcSEcCtD
Sertraline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000166	0.000424	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000165	0.000421	CcSEcCtD
Sertraline—Urticaria—Methotrexate—lymphatic system cancer	0.00016	0.000409	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—lymphatic system cancer	0.00016	0.000407	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—lymphatic system cancer	0.00016	0.000407	CcSEcCtD
Sertraline—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000149	0.000379	CcSEcCtD
Sertraline—Asthenia—Methotrexate—lymphatic system cancer	0.000145	0.000369	CcSEcCtD
Sertraline—Pruritus—Methotrexate—lymphatic system cancer	0.000143	0.000364	CcSEcCtD
Sertraline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000138	0.000352	CcSEcCtD
Sertraline—Dizziness—Methotrexate—lymphatic system cancer	0.000134	0.00034	CcSEcCtD
Sertraline—Vomiting—Methotrexate—lymphatic system cancer	0.000128	0.000327	CcSEcCtD
Sertraline—Rash—Methotrexate—lymphatic system cancer	0.000127	0.000324	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—lymphatic system cancer	0.000127	0.000324	CcSEcCtD
Sertraline—Headache—Methotrexate—lymphatic system cancer	0.000127	0.000322	CcSEcCtD
Sertraline—Nausea—Methotrexate—lymphatic system cancer	0.00012	0.000306	CcSEcCtD
